Total planned funding: $820,063,691
Allocations
Countries/Regions
| Nigeria | $161,279,687 |
| Tanzania | $140,448,382 |
| Zambia | $120,468,727 |
| Kenya | $87,430,000 |
| Mozambique | $52,815,852 |
| Uganda | $41,483,402 |
| Zimbabwe | $34,283,622 |
| Rwanda | $33,507,037 |
| Ethiopia | $30,932,540 |
| Côte d'Ivoire | $21,358,986 |
| South Africa | $21,067,947 |
| Democratic Republic of the Congo | $16,224,377 |
| Vietnam | $12,438,876 |
| Haiti | $11,824,484 |
| Namibia | $9,714,332 |
| Eswatini | $8,626,326 |
| Ukraine | $5,044,691 |
| Malawi | $3,398,292 |
| Lesotho | $2,150,000 |
| Botswana | $1,335,776 |
| Cameroon | $888,196 |
| Ghana | $852,192 |
| Guyana | $772,197 |
| South Sudan | $659,928 |
| Indonesia | $369,159 |
| Central America Region | $366,370 |
| Burundi | $322,313 |
Organizational Types
| Private Contractor | $820,063,691 |
Program Areas
| Treatment | $820,063,691 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $602,255,581 |
| HTXS: Treatment: Adult Treatment | $197,776,209 |
| PDTX: Treatment: Pediatric Treatment | $20,031,901 |
Top Partner Programs
Chemonics International:
$521,749,028
View countries
Deloitte Consulting Limited:
$15,429,489
View countries